import { media, type Media } from "./media";

/**
 * Demo editorial. Every regulatory fact below is drawn from the verified public
 * record in `01 §4`; nothing here asserts a firm outcome, client or credential.
 *
 * The section renders only at three or more pieces. `01 D-10`.
 */
export type Insight = {
  readonly slug: string;
  readonly title: string;
  readonly category: "Reimbursement" | "Policy" | "Approval" | "Market entry";
  readonly description: string;
  /** ISO. Rendered through --t-data because it is checkable. */
  readonly datePublished: string;
  readonly displayDate: string;
  readonly readingTime: string;
  readonly image: Media;
};

export const insights: readonly Insight[] = [
  {
    slug: "sha-benefits-package-registered-product",
    title: "What the SHA benefits package means for a registered product",
    category: "Reimbursement",
    description:
      "Coverage under the Social Health Authority flows through three funds. What that structure changes for a product that already holds Pharmacy and Poisons Board registration.",
    datePublished: "2026-02-10",
    displayDate: "10 February 2026",
    readingTime: "6 min read",
    image: media.insight1,
  },
  {
    slug: "reading-the-bptap-mandate",
    title: "Reading the BPTAP mandate: what the panel actually assesses",
    category: "Policy",
    description:
      "The Benefits Package and Tariffs Advisory Panel was gazetted in April 2025. What its published mandate covers, and what it does not.",
    datePublished: "2026-01-22",
    displayDate: "22 January 2026",
    readingTime: "8 min read",
    image: media.insight2,
  },
  {
    slug: "what-drives-a-ppb-review-timeline",
    title: "What actually drives a PPB review timeline",
    category: "Approval",
    description:
      "Review duration is mostly a function of dossier quality and query handling. Where the time goes, and which parts an applicant controls.",
    datePublished: "2025-12-04",
    displayDate: "4 December 2025",
    readingTime: "5 min read",
    image: media.insight3,
  },
  {
    slug: "eac-harmonisation-and-the-second-market",
    title: "EAC harmonisation and the cost of the second market",
    category: "Market entry",
    description:
      "The East African Community medicines regulatory harmonisation framework reduces duplication across member states. What still has to be rebuilt per market.",
    datePublished: "2025-11-06",
    displayDate: "6 November 2025",
    readingTime: "7 min read",
    image: media.insight4,
  },
];

export function getInsight(slug: string): Insight | undefined {
  return insights.find((post) => post.slug === slug);
}
